Homer Glen board votes to ban nitrous oxide to prevent recreational use
The Homer Glen Village Board voted Wednesday to ban nitrous oxide sales after village officials learned some people buy the product in tobacco and vape stores for recreational drug use.
Nitrous oxide is a colorless, nonflammable gas that is used as an anesthetic, such as laughing gas, or to dispense whipped cream.
But flavored nitrous oxide canisters have become popular and offer a variety of different sized containers to purchase, village officials said. When inhaled, the user can get a euphoria or high.
The U.S. Food and Drug Administration issued a warning earlier this year that intentional misuse or inhalation can lead to serious problems including asphyxiation, blood clots, loss of consciousness, palpitations, paralysis, psychiatric disturbances and other adverse health effects.
Regularly inhaling nitrous oxide can lead to prolonged neurological effects, including spinal cord or brain damage, even after stopping the use, the FDA said. It can also lead to death, the FDA said.
'We don't need it in our village,' said Homer Glen Trustee Curt Mason, chair of the village's Public Services and Safety Committee. 'It's another addiction. It's another method for people to make money off the demise of our children, and it's not going to happen here.'
Nitrous oxide is sold under multiple brand names such as Galaxy Gas, MassGass, and Whip-it!, according to the FDA.
Village Manager Joe Baber said because of way it can be misused, it's concerning. Flavored nitrous oxide containers appear to be marketed to children, he said.
'We are trying to nip it before it becomes a problem in Homer Glen,' said Baber, who also chairs the village's Behavioral Health and Addiction Recovery Committee.
Homer Glen officials modeled their ordinance on the village of Manhattan, whose officials banned the sale of nitrous oxide containers last year.
Manhattan Village Administrator Jeff Wold said officers were concerned seeing nitrous oxide cartridges or canisters in cars during traffic stops, including teenaged drivers.
Officials found that the products were sold online on retailers such as Amazon and also next to cigarettes and vaping products in stores that aren't selling whipped cream, Wold said.
The Manhattan Village Board approved the ban on nitrous oxide sales in February 2024. Wold said the village sent tobacco and vape shops certified mail, and he spoke personally with the managers of the stores to let them know of the ordinance.
The village gave the stores a few weeks to remove the product from their shelves, and the village has not had an issue with compliance in the past year, Wold said.
The Will County Health Department does not have data on nitrous oxide usage.
'Nitrous oxide containers sold in tobacco/vape stores allows for easier access and this poses a threat to young people,' Dr. Kathleen Burke, the program coordinator for substance use initiatives at the Will County Health Department, said in a statement. 'They are able to purchase the containers and use the nitrous oxide to get high. Without preventing vape/tobacco stores from selling the product, it is very difficult to stop the misuse.'
In Homer Glen, liquor, tobacco and vape shops caught selling nitrous oxide would face a maximum fine of $500 for the first offense and could have their business license revoked if they were caught a second time, Baber said.
The Will County sheriff's office conducts compliance checks on liquor and tobacco stores to ensure they aren't selling items to underaged consumers, and officers could check they aren't selling nitrous oxide as well, Baber said.
Homer Glen Trustee Nicholas Muller, a sergeant with the Oak Forest Police Department, said banning the sales of nitrous oxide makes sense for the public health and safety of the village.
It was only recently that a man in his 20s who had used nitrous oxide was involved in a crash and hit a bus shelter near 159th Street and Cicero Avenue, Muller said. A few years ago, a teenager who had used nitrous oxide crashed into a tree, Muller said.
'You don't know what it will do to someone's mental state,' Muller said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
WebMD
43 minutes ago
- WebMD
FDA Approves New 3-in-1 Combo Pill for High Blood Pressure
June 11, 2025 – The FDA has approved a new pill for adults with high blood pressure (hypertension) that combines three medicines in one. Available in one regular and two lower doses, it offers a convenient option for treating hypertension, which affects nearly half of the adults in the U.S. and raises their risk of stroke and heart failure. Sold as Widaplik, it is the first and only single pill to combine three previously FDA-approved drugs – telmisartan, amlodipine, and indapamide – offering a triple-action approach for people who would otherwise need multiple pills to manage their blood pressure. It works in three ways and is a safe, well-tolerated early treatment option. Hypertension happens when your blood pushes too hard against your blood vessels, making the heart work harder and increasing the risk of heart problems, strokes, and other complications. It contributes to about 460,000 deaths annually in the U.S. and often goes undetected due to a lack of symptoms. With 1 in 3 Americans unaware they have it and only 1 in 4 managing it well, there's an urgent need for simpler, more effective treatments. The approval was based on two large studies that showed using Widaplik helped lower blood pressure more than using just two medicines or a placebo, according to a news release from the company that makes it, George Medicines. People who took Widaplik didn't stop taking it more often because of side effects, which means it was generally easy for them to take. Another trial showed that Widaplik was better at reducing blood pressure compared to standard care, while remaining well-tolerated. George Medicines stated that a global trial is underway to find out if the combo treatment can help prevent strokes in people who have previously had an intracerebral hemorrhage (sudden bleeding in the brain), the most serious type of stroke. "Single-pill combination antihypertensive therapy has great potential to improve hypertension control in the US and worldwide. Most patients with hypertension need multiple therapies to achieve their blood pressure goals. The new dose options available with Widaplik offer a treatment regimen that could benefit a broad range of patients, including those just starting treatment," Paul Whelton, MD, Show Chwan chair of global public health at Tulane University in New Orleans and past president of the World Hypertension League, said in a statement. Widaplik is a medicine made of three drugs that work together to help lower blood pressure. Two of them, telmisartan and amlodipine, relax blood vessels so blood can flow more easily. The third, indapamide, helps your body get rid of extra water by making you pee more. Widaplik comes in three strengths: 10/1.25/0.625 mg, 20/2.5/1.25 mg, and 40/5/2.5 mg. Low blood pressure – which can make you feel faint or dizzy – was the most common side effect, the company said. Patients who pass out should stop taking the medication and consult their doctor.
Yahoo
an hour ago
- Yahoo
Urgent fish recall issued over botulism concerns
Fish sold in multiple U.S. states have been urgently recalled because they may have been contaminated with Clostridium botulinum, a bacterium that can cause illness or death. P. East Trading Corp. is recalling its Salted Smoked Split Herring, according to a press release shared by the U.S. Food and Drug Administration (FDA) on Tuesday. The product is five inches in length and uneviscerated, meaning they had not had its internal organs removed. According to the FDA, the recalled fish may contain Clostridium botulinum spores that cause botulism, 'as they are more likely to be concentrated in the viscera than any other portion of the fish.' Botulism is a rare but serious condition caused by a toxin that attacks the body's nerves. Symptoms include general weakness, dizziness, double-vision, trouble with speaking or swallowing, difficulty in breathing, abdominal distension, and constipation. The recall came after the Salted Smoked Split Herring was sampled by a New York State Department of Agriculture and Markets Food Inspector. A subsequent analysis of the product confirmed that the 'herring was not properly eviscerated prior to processing.' There have been no reported illnesses so far. The recalled fish was sold at retail locations in Connecticut, New Jersey, and New York. It was sold in 18-pound wooden boxes with the container code Lot 1 PRC5073. However, the FDA noted that the product could have been repacked by retail store workers in 'deli-style or other retail packaging.' A specific list of the stores that received and potentially sold the herring can be found here. Consumers are urged not to eat the recalled herring. Instead, they should return the product to the place of purchase for a full refund. This isn't the only product that's been recalled due to a risk of botulinum. In April, Walker's Wine Juice recalled its pumpkin juice, sold in 12 states, because it may have contained the potentially fatal form of food poisoning. The recall was issued after the New York State Department of Agriculture and Markets Food Inspectors discovered the juice's pH was 'too high to be processed per Walker's 'hot fill' schedule process.' The recall applied to all lots of Walker's Wine Juice's 2.5-gallon bag in a box and 5-gallon hot pack labeled 'pumpkin' in addition to their 30-, 60-, and 275-gallon bulk containers also labeled 'pumpkin.' The last two years have also seen an alarming and unexplained rise in recalls. In 2024, approximately 300 food recalls were issued, with those recalls being linked to nearly 1,400 illnesses, a Public Interest Research Group report revealed. Out of the 1,400 illnesses, 487 people became sick enough to require hospitalization, and 19 people died. While those numbers are still low when weighed against the entire U.S. population, they are also double the number of hospitalizations and deaths from food-borne illnesses in 2023. In May, cucumbers sold across the country were recalled after people in 15 states reported getting ill from salmonella. Florida-based Bedner Growers, Inc. recalled the vegetables distributed by Fresh Start Produce Sales, Inc. from April 29 to May 19.
The Hill
an hour ago
- The Hill
Lawmakers urge Trump administration to clamp down on illicit GLP-1 sales
A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing these drugs without knowing the product could be fraudulent. North Carolina Reps. Brad Knott (R) and Deborah Ross (D) wrote to Food and Drug Administration (FDA) Commissioner Marty Makary, Homeland Security Secretary Kristi Noem and U.S. Attorney General Pam Bondi, imploring them to end the sale of 'counterfeit, research-grade and illegal copycats' of popular GLP-1 medications. When the commercial, branded versions of tirzepatide and semaglutide were declared to no longer be in shortage, compounding pharmacies were disallowed from continuing to sell compounded versions of those drugs. While telehealth companies have transitioned away from compounded versions, state officials have warned that 'copycat' drugs have proliferated in the months since the shortages ended. Earlier this year, the National Association of Attorneys General sent a letter to the FDA to warn that 'counterfeit GLP-1 drugs have infiltrated the U.S. supply chain from China, Turkey, India, and other foreign sources.' According to the attorneys general, online retailers sell the active ingredient for the GLP-1s under the claim that they're 'for research purposes only' or 'not for human consumption' while still marketing them to consumers on social media. The FDA issued a warning in April, telling consumers to not take counterfeit Ozempic. The drug's manufacturer, Novo Nordisk, had alerted the agency that several hundred units of counterfeit product had entered the U.S. supply chain. At the time, the FDA said it was aware of six adverse events associated with the counterfeit products. Though the FBI issued a public service warning soon after the letter from the attorneys general was sent, Knott and Ross said raising public awareness wasn't enough. 'FDA has received hundreds of reports of adverse events, even some resulting in the hospitalization and death of patients who used illicit GLP-1s,' they wrote. 'This is likely a significant underreporting of adverse events experienced by patients because federal law does not require state-licensed pharmacies that are not outsourcing facilities to submit adverse events to FDA.' The lawmakers asked that the Trump Cabinet members fully use 'the legal tools at your discretion' to further detect illicit and enforce U.S. drug standards. Sen. Thom Tillis (R-N.C.) sent his own letter to Cabinet members, calling for enhanced collaboration among agencies like FDA, U.S. Customs and Border Protection and the Justice Department in order to stop the counterfeit products from reaching the supply chain in the first place. The Hill has reached out to the agencies named in the letter for comment.
